The FDA approved its first oral drug intended to treat postpartum depression. Postpartum depression affects an estimated 400,000 people each year, and while it often only lasts for a couple weeks, it can continue for months or even years for some (AP, August 4).
Last week, CMS ceased handling payment disputes between providers and insurers related to the No Surprises Act. The pause comes after U.S. District Court for the Eastern District of Texas, Judge Jeremy Kernodle, ruled that the fee increase and batching requirement sections of the Act violate the rulemaking requirement and are therefore void (Modern Healthcare, August 7).
According to a study published by the American Academy of Pediatrics, approximately 1 in 6 toddlers, or 17%, are not getting all the needed doses for early-childhood vaccinations. These incomplete vaccinations leave children vulnerable to preventable diseases and decrease the maintenance of herd immunity at a population level (The Washington Post, August 7).
From August 2 through August 9, CMS approved 18 SPAs, five of which are COVID-19 disaster relief SPAs, and one Appendix K.